ALNYLAM PHARMACEUTICALS is Biopharmaceutical company with headquarters is in Massachusetts, USA.ALNYLAM leaders from the biopharmaceutical industry, bringing together their experiences of drug discovery, drug development, and commercialization.Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.
ALNYLAM PHARMACEUTICALS was NEW CLINICAL PROGRAMS ADDED IN 2021 and 2.4 BILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT YEAR-END 2021.
As on 2022, ALNYLAM PHARMACEUTICALS has 2,002 employees.